ClinicalTrials.gov
ClinicalTrials.gov Menu

Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01314274
Recruitment Status : Completed
First Posted : March 14, 2011
Last Update Posted : August 12, 2013
Sponsor:
Information provided by (Responsible Party):
Martin Burian, Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : June 2013